Patrick Plésiat

5.6k total citations
99 papers, 4.2k citations indexed

About

Patrick Plésiat is a scholar working on Molecular Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, Patrick Plésiat has authored 99 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Molecular Medicine, 43 papers in Molecular Biology and 22 papers in Pharmacology. Recurrent topics in Patrick Plésiat's work include Antibiotic Resistance in Bacteria (86 papers), Bacterial biofilms and quorum sensing (39 papers) and Antibiotics Pharmacokinetics and Efficacy (22 papers). Patrick Plésiat is often cited by papers focused on Antibiotic Resistance in Bacteria (86 papers), Bacterial biofilms and quorum sensing (39 papers) and Antibiotics Pharmacokinetics and Efficacy (22 papers). Patrick Plésiat collaborates with scholars based in France, Belgium and Germany. Patrick Plésiat's co-authors include Thilo Köhler, Katy Jeannot, Sophie de Bentzmann, Didier Hocquet, Julio Aires, Catherine Llanes, Hiroshi Nikaido, Pierre‐Edouard Fournier, Patrice Nordmann and M. Roussel‐Delvallez and has published in prestigious journals such as PLoS ONE, Applied and Environmental Microbiology and Clinical Infectious Diseases.

In The Last Decade

Patrick Plésiat

96 papers receiving 4.0k citations

Peers

Countries citing papers authored by Patrick Plésiat

Since Specialization

Citations

This map shows the geographic impact of Patrick Plésiat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Plésiat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Plésiat more than expected).

Fields of papers citing papers by Patrick Plésiat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Plésiat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Plésiat. The network helps show where Patrick Plésiat may publish in the future.

Co-authorship network of co-authors of Patrick Plésiat

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Plésiat. A scholar is included among the top collaborators of Patrick Plésiat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Plésiat. Patrick Plésiat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Intracellular Pseudomonas aeruginosa persist and evade antibiotic treatment in a wound infection model 2025 ·PLoS Pathogens ·(unknown), (unknown), Laurence Berry, Anne Bonhoure, Morgan A. Alford, (unknown), (unknown), Manjeet Bains, Olivier Lesouhaitier, Robert E. W. Hancock, Patrick Plésiat, Anne‐Béatrice Blanc‐Potard	7
2	Role of the two-component system AmgRS in early resistance of Pseudomonas aeruginosa to cinnamaldehyde 2024 ·Microbiology Spectrum ·Eline A. Dubois, (unknown), Patrick Plésiat, Catherine Llanes	1
3	Synthesis and antibacterial properties under blue LED light of conjugates between the siderophore desferrioxamine B (DFOB) and an Iridium(III) complex 2024 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), Inokentijs Josts, (unknown), Jean‐Luc Renaud, Françoise Hoegy, Patrick Plésiat, Henning Tidow, Sylvain Gaillard, Gaëtan L. A. Mislin	3
4	Evaluation of 5 rapid colorimetric and immunochromatographic tests for the detection of carbapenemases in Pseudomonas aeruginosa and Acinetobacter spp. isolates 2023 ·European Journal of Clinical Microbiology & Infectious Diseases ·Pierre‐Edouard Fournier, (unknown), (unknown), Patrick Plésiat, Katy Jeannot, Anaïs Potron	1
5	Cefiderocol activity is compromised by acquired extended-spectrum oxacillinases in Pseudomonas aeruginosa 2023 ·International Journal of Antimicrobial Agents ·(unknown), (unknown), Maxime Bour, Céline Landon, Patrick Plésiat, Katy Jeannot	11
6	Genomic characterization of an NDM-9-producing Acinetobacter baumannii clinical isolate and role of Glu152Lys substitution in the enhanced cefiderocol hydrolysis of NDM-9 2023 ·Frontiers in Microbiology ·(unknown), Saoussen Oueslati, (unknown), Maxime Bour, Bogdan I. Iorga, (unknown), Patrick Plésiat, Rémy A. Bonnin, Thierry Naas, Katy Jeannot, Anaïs Potron	12
7	Performance of discs, sensititre EUMDROXF microplates and MTS gradient strips for the determination of the susceptibility of multidrug-resistant Pseudomonas aeruginosa to cefiderocol 2022 ·Clinical Microbiology and Infection ·(unknown), (unknown), (unknown), Maxime Bour, Patrick Plésiat, (unknown), (unknown)	19
8	Detection of Colistin Resistance in Pseudomonas aeruginosa Using the MALDIxin Test on the Routine MALDI Biotyper Sirius Mass Spectrometer 2021 ·Frontiers in Microbiology ·Katy Jeannot, (unknown), Laurent Dortet, Markus Kostrzewa, Alain Filloux, Patrick Plésiat, Gerald Larrouy‐Maumus	22
9	1,2,3-Triazole-gold(I)-triethylposphine derivatives active against resistant Gram-positive pathogens 2021 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Jean‐Marie Contreras, Christophe Morice, Isabelle J. Schalk, Patrick Plésiat, Gaëtan L. A. Mislin	6
10	Involvement of the Pseudomonas aeruginosa MexAB–OprM efflux pump in the secretion of the metallophore pseudopaline 2020 ·Molecular Microbiology ·Nicolas Gomez, (unknown), Laurent Ouerdane, (unknown), Catherine Brutesco, Geneviève Ball, Ryszard Łobiński, Yann Denis, Patrick Plésiat, Catherine Llanes, Pascal Arnoux, Romé Voulhoux	15
11	Improvement of a disk diffusion method for antibiotic susceptibility testing of anaerobic bacteria. French recommendations revisited for 2020 2020 ·Anaerobe ·L. Dubreuil, F. Jehl, C. Cattoën, Richard Bonnet, (unknown), François Caron, Vincent Cattoir, Patrice Courvalin, Vincent Jarlier, Gérard Lina, Audrey Mérens, Patrick Plésiat, (unknown), Claude–James Soussy, Emmanuelle Varon, Philippe Weber	19
12	Study of 109 Achromobacter spp. isolates from 9 French CF centres reveals the circulation of a multiresistant clone of A. xylosoxidans belonging to ST 137 2019 ·Journal of Cystic Fibrosis ·Lucie Amoureux, (unknown), (unknown), (unknown), (unknown), (unknown), Julien Bador, (unknown), J. Caillon, (unknown), Vincent Cattoir, Anne Doléans-Jordheim, Agnès Ferroni, Hélène Guet‐Revillet, Geneviève Héry-Arnaud, Christine Segonds, (unknown), Patrick Plésiat, Hoang Vu-Thien	18
13	In vitro activities of a new fluoroquinolone derivative highly active against Chlamydia trachomatis 2018 ·Bioorganic Chemistry ·(unknown), Nguyêt‐Thanh Ha‐Duong, Alexandra Aubry, (unknown), (unknown), Patrick Plésiat, Philippe Verbeke, Nawal Serradji	15
14	Antibiotic Resistance Determinants in a Pseudomonas putida Strain Isolated from a Hospital 2014 ·PLoS ONE ·Lázaro Molina, Zulema Udaondo, Estrella Duque, Matilde Fernández, Carlos Molina‐Santiago, Amalia Roca, Mario Porcel, Jesús de la Torre, Ana Segura, Patrick Plésiat, Katy Jeannot, Juan L. Ramos	71
15	Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa 2013 ·Journal of Antimicrobial Chemotherapy ·Pierre‐Edouard Fournier, (unknown), (unknown), (unknown), Catherine Llanes, Patrick Plésiat, Katy Jeannot	67
16	Diversity of -lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study 2013 ·Journal of Antimicrobial Chemotherapy ·Catherine Llanes, Christine Pourcel, (unknown), Patrick Plésiat, Gwennaële Fichant, J.-D. Cavallo, Audrey Mérens, (unknown), (unknown), (unknown), (unknown), (unknown), Hélène Marchandin, Édouard Bingen, Christine Segonds, J. Caillon, M. Roussel‐Delvallez, Gilles Vergnaud, Didier Hocquet, (unknown)	59
17	Alternatives to carbapenems in ESBL-producing Escherichia coli infections 2013 ·Médecine et Maladies Infectieuses ·Pierre‐Edouard Fournier, Catherine Chirouze, J. Leroy, Pascal Cholley, D. Talon, Patrick Plésiat, Xavier Bertrand	44
18	The Pseudomonas aeruginosa opportunistic pathogen and human infections 2011 ·Environmental Microbiology ·Sophie de Bentzmann, Patrick Plésiat	234
19	Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump 2008 ·HAL (Le Centre pour la Communication Scientifique Directe) ·Katy Jeannot, Sylvie Elsen, Thilo Köhler, Ina Attrée, Christian van Delden, Patrick Plésiat	6
20	Genotypic and Phenotypic Analysis of Type III Secretion System in a Cohort ofPseudomonas aeruginosaBacteremia Isolates: Evidence for a Possible Association between O Serotypes andexoGenes 2003 ·The Journal of Infectious Diseases ·P. Berthelot, Ina Attrée, Patrick Plésiat, Jacqueline Chabert, Sophie de Bentzmann, Bruno Pozzetto, Florence Grattard, (unknown)	81

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact